Vaccination with nanoparticles combined with micro-adjuvants protects against cancer

Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy

(2018) M. Worm et al.   ALLERGY

Vaccination against IL-31 for the treatment of atopic dermatitis in dogs

(2018) Martin F. Bachmann et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Treating insect-bite hypersensitivity in horses with active vaccination against IL-5

(2018) Antonia Fettelschoss-Gabriel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Microcrystalline Tyrosine and Aluminum as Adjuvants in Allergen-Specific Immunotherapy Protect from IgE-Mediated Reactivity in Mouse Models and Act Independently of Inflammasome and TLR Signaling

(2018) Deborah S. Leuthard et al.   JOURNAL OF IMMUNOLOGY

The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide

(2018) Chunhui Lai et al.   Theranostics

Clinical use of adjuvants in allergen-immunotherapy

(2017) Ludger Klimek et al.   Expert Review of Clinical Immunology

Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination

(2017) Mona O. Mohsen et al.   JOURNAL OF CONTROLLED RELEASE

Major findings and recent advances in virus–like particle (VLP)-based vaccines

(2017) Mona O. Mohsen et al.   SEMINARS IN IMMUNOLOGY

Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?

(2017) Andrew L. Mellor et al.   Frontiers in Immunology

Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy

(2017) Andris Zeltins et al.   npj Vaccines

Vaccine adjuvants as potential cancer immunotherapeutics

(2016) Burcu Temizoz et al.   INTERNATIONAL IMMUNOLOGY

Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes

(2016) Claudia Cavelti-Weder et al.   MOLECULAR THERAPY

Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy

(2016) Nayoung Lee et al.   PATHOLOGY

Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope

(2016) P. Baumgaertner et al.   OncoImmunology

Adjuvants for peptide-based cancer vaccines

(2016) Hiep Khong et al.   Journal for ImmunoTherapy of Cancer

Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs

(2015) Rachid Ammi et al.   PHARMACOLOGY & THERAPEUTICS

Reflections on the Histopathology of Tumor-Infiltrating Lymphocytes in Melanoma and the Host Immune Response

(2015) M. C. Mihm et al.   Cancer Immunology Research

Whole-Body Imaging with Single-Cell Resolution by Tissue Decolorization

(2014) Kazuki Tainaka et al.   CELL

Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages

(2014) Meera Rath et al.   Frontiers in Immunology

Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion

(2013) Yared Hailemichael et al.   NATURE MEDICINE

Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+T-cell responses in melanoma patients

(2012) Simone M. Goldinger et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Copper-free click chemistry in living animals

(2010) P. V. Chang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study

(2008) Alain C Tissot et al.   LANCET